All GLG News Analyses Filed Under: Ophthalmology

1. glaucoma treatment 2. combined therapy 3. IOP reduction

A recent study showed that children aged 8-12 were just as successful as teenagers aged 13-17 in the areas of physiological adjustment and contact lens care.  I find this is true in my practice as well.  Not only can prescribing to this younger demographic change a child's life, it can...

The recent purchase by Bausch & Lomb of Eyeonics shows a good move to capture the growing presbyopic correction market. The company has also sent Ronald L. Zarrella to become chairman emeritus. One of the best moves I have heard since the whole Renu problem.

With the recent trends of presbyopic correction , Bausch and Lomb has now entered the arena.

I HAVE BEEN PRODICTING THAT A MAJOR PLAYER WOULD BUY EYEONICS SINCE I FIRST STARTED PLACING THE CRYSTALENS IN MY PATIENTS. THE LENS WORKS BUT NEEDED A PRO AT MARKETING. B& L WILL BENIFIT FROM THIS BUY.

As ophthalmologists, we have been waiting for development of a useful telescopic intraocular lens implant for over 17 years. These lenses have been in FDA trials for years, but never brought to market because of numerous problems with them. A viable telescopic lens implant would give us something to...

Macular degeneration is a condition where the central part of the retina is lost. This item places an image on the retina that is so big, it allows the use of the remaining, useful retina. Sounds great! It may be, however, as with many low vision devices, there are some potential pitfalls.

"Customized" intraocular lenses are gradually making their way into the mainstream of ocular surgery. First there were multifocal and accommodating IOLs. Now there are toric IOLs. And the future is upon us for more sophisticated designs such as the telescopic IOL.  As with any new technology,...

The potential market for a newer and better optical solution to the problem of presbyopia is limitless.  Any optical system which functions with fewer "compromises" than those we have now will be a welcome addition even if its application is limited to just contact lenses alone. Broader applications...

-Retinal community unites against Genentech -both the American Association of Ophthalmology and the American Society of Retinal Specialists have condemned Genentech's actions -this represents profit-driven pharma at their worst -very poor decision by Genentech...not only to galvanize the profession...